Hypertrophic Cardiomyopathy: Long Term Survival with Alcohol Septal Ablation according to Hemodynamic Variables

Left ventricular outflow tract (LVOT) obstruction is an integral component of hypertrophic cardiomyopathy (HCM). Both chemical myomectomy and alcohol septal ablation (ASA) have been shown effective in the reduction of residual gradients and symptoms in several studies and clinical registries, and are normally reserved for patients who continue experiencing symptoms despite medical treatment. 

Miocardiopatía Hipertrófica

Even though hemodynamic predictors of cardiovascular events (such as post ASA residual gradient) have been looked into, little is known about the impact of other objective parameters that could be measured by heart catheterization. The aim of this study was to assess whether changes before and after ASA might influence outcomes at long term. 

Data from symptomatic HCM patients who had received ASA and heart catheterization by transseptal route (more accurate than the retro-aortic approach) at the Mayo Clinic were gathered retrospectively. Aortic pressure was measured (systolic and diastolic), as well as LV pressure (systolic, diastolic and end-diastolic), atrial (A, V and mean waves) and LVOT gradient (peak to peak). 

Mean patient age was 67.3±4.7, with mean body mass index (BMI) 30.2, and 46.2% were women. 65.2% were hypertensive and 42% had known heart disease. Resting gradients were >50 mmHg in 56.4% of cases, with mean septal thickness 9.2 mm.  ASA patients saw a reduction in all variables except for LV end diastolic pressure. P-P gradient saw the biggest change (76.4%), followed by atrial V wave (19.1%) and pulse pressure (-17%).

Read also: Is Complete Revascularization Really Necessary after AMI in the Elderly?

At 10 year followup, survival was over 50%. Baseline mean LVOT pressure gradient >19 mmHg was associated with adverse events and survival predictors were identified as percentage change in pulse pressure (P=0.31) and LVOT gradient (P<0.001). 

Multivariable analysis showed predictors of mortality at long term were baseline left atrial V wave pressure > median (28 mm Hg; HR, 2.36 [95% CI, 1.17–4.76]; P=0.016), baseline mean LA pressure > median (19 mm Hg; HR, 2.70 [95% CI, 1.33–5.50]; P=0.006), pulse pressure increase ≤19.3% (HR, 2.09 [95% CI, 1.05–4.16]; P=0.035), and LVOT gradient reduction ≤82% (HR, 2.74 [95% CI, 1.37–5.50]; P=0.005).

NYHA functional class was 2.97±0.31 at baseline, 1.47±0.67 at 30 days, and 1.77±0.7 at last followup.

Conclusion

This retrospective study showed that a group of patients with specific hemodynamic variables saw improved symptoms assessed by functional class, as well as improved survival at long term. This was especially true for patients with low atrial V wave, low LA baseline pressure, significant LVOT reduction and increased pulse pressure. 

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

Reference: Alabdaljabar, Mohamad S et al. “Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.” Circulation. Cardiovascular interventions vol. 16,8 (2023): e013068. doi:10.1161/CIRCINTERVENTIONS.123.013068.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...